Literature DB >> 19182530

TAp73alpha binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy.

Patrizia Vernole1, Michael H Neale, Daniela Barcaroli, Eliana Munarriz, Richard A Knight, Richard Tomasini, Tak W Mak, Gerry Melino, Vincenzo De Laurenzi.   

Abstract

Aneuploidy is a characteristic of most solid tumors, often associated with negative prognosis. It can arise from two principal mechanisms: from a tetraploid intermediate state, or directly from errors at cell division. The control of cell division, crucial to maintain genomic stability, is still poorly understood in its relationship to aneuploidy. Here we show that the TAp73alpha isoform induces polyploidy when overexpressed. This is possibly due to the interaction of TAp73alpha with kinetochore-related proteins leading to the alteration of mitotic checkpoint abilities. TAp73alpha but not p53 or any of the other p73 isoforms binds Bub1 and Bub3. Since TAp73alpha is frequently overexpressed in cancer, this interaction may contribute to the aneuploidy observed in cancer progression. Our results suggest a novel molecular mechanism leading to aneuploidy involving interference of TAp73alpha with Bub1 and Bub3 resulting in an altered mitotic checkpoint.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19182530     DOI: 10.4161/cc.8.3.7623

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  18 in total

Review 1.  Normal and malignant megakaryopoiesis.

Authors:  Qiang Wen; Benjamin Goldenson; John D Crispino
Journal:  Expert Rev Mol Med       Date:  2011-10-21       Impact factor: 5.600

2.  Overexpression of the ∆Np73 isoform is associated with centrosome amplification in brain tumor cell lines.

Authors:  Erika Mikulenkova; Jakub Neradil; Karel Zitterbart; Jaroslav Sterba; Renata Veselska
Journal:  Tumour Biol       Date:  2015-04-25

3.  Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73.

Authors:  Hiroshi Katayama; Jin Wang; Warapen Treekitkarnmongkol; Hidehiko Kawai; Kaori Sasai; Hui Zhang; Hua Wang; Henry P Adams; Shoulei Jiang; Sandip N Chakraborty; Fumio Suzuki; Ralph B Arlinghaus; Jinsong Liu; James A Mobley; William E Grizzle; Huamin Wang; Subrata Sen
Journal:  Cancer Cell       Date:  2012-02-14       Impact factor: 31.743

Review 4.  p53: guardian of ploidy.

Authors:  Yael Aylon; Moshe Oren
Journal:  Mol Oncol       Date:  2011-07-30       Impact factor: 6.603

5.  Regulation of female reproduction by p53 and its family members.

Authors:  Zhaohui Feng; Cen Zhang; Hey-Joo Kang; Yvonne Sun; Haijian Wang; Asad Naqvi; Amanda K Frank; Zev Rosenwaks; Maureen E Murphy; Arnold J Levine; Wenwei Hu
Journal:  FASEB J       Date:  2011-03-14       Impact factor: 5.191

6.  p73 in Cancer.

Authors:  Alessandro Rufini; Massimiliano Agostini; Francesca Grespi; Richard Tomasini; Berna S Sayan; Maria Victoria Niklison-Chirou; Franco Conforti; Tania Velletri; Antonio Mastino; Tak W Mak; Gerry Melino; Richard A Knight
Journal:  Genes Cancer       Date:  2011-04

7.  p73α1, a p73 C-terminal isoform, regulates tumor suppression and the inflammatory response via Notch1.

Authors:  Kyra Nicole Laubach; Wensheng Yan; Xiangmudong Kong; Wenqiang Sun; Mingyi Chen; Jin Zhang; Xinbin Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-26       Impact factor: 12.779

8.  BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).

Authors:  Y Niikura; H Ogi; K Kikuchi; K Kitagawa
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

9.  p53 regulates a mitotic transcription program and determines ploidy in normal mouse liver.

Authors:  Svitlana Kurinna; Sabrina A Stratton; Zeynep Coban; Jill M Schumacher; Markus Grompe; Andrew W Duncan; Michelle Craig Barton
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

10.  Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.

Authors:  Jackson R Taylor; Brian D Lehmann; William H Chappell; Stephen L Abrams; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2011-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.